Join Now

Author Archives: Natalie Themm

Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research

By Natalie Themm | Published February 22, 2024

SALT LAKE CITY, UT, February 22, 2024 (BusinessWire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development. With nearly 20 years of experience in R&D, phenotypic drug discovery, and assay and scientific operations, O’Mahony […]

Posted in BioUtah News | Tagged | Comments Off on Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research

Nomi Health Announces Advisory Board to Guide Integrated Care Programs, Closing Gaps in Care for Patients Served by Payers and Providers

By Natalie Themm | Published February 22, 2024

Company Introduces Success Care to Tackle Substance Use Disorder Treatment

Posted in BioUtah News | Tagged | Comments Off on Nomi Health Announces Advisory Board to Guide Integrated Care Programs, Closing Gaps in Care for Patients Served by Payers and Providers

Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees

By Natalie Themm | Published February 22, 2024

Recipients’ research focused on melanoma diagnosis, treatment response in advanced NSCLC, and bypassing common hurdles in NSCLC diagnosis and treatment

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees

Thermo Fisher Scientific Recognized by Customers for Contract Manufacturing Leadership

By Natalie Themm | Published February 22, 2024

Pharma and biotech customers distinguish excellence in capabilities, compatibility, expertise, quality and reliability

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Recognized by Customers for Contract Manufacturing Leadership

Utah Legislative Recap – February 15, 2024

By Natalie Themm | Published February 15, 2024

Utah Legislative Recap – Updated February 15, 2024

Posted in BioUtah News | Tagged | Comments Off on Utah Legislative Recap – February 15, 2024

Eris Biotech accepted to Y Combinator

By Natalie Themm | Published February 8, 2024

Eris Biotech accepted to Y Combinator

Posted in BioUtah News | Tagged | Comments Off on Eris Biotech accepted to Y Combinator

Clene Inc. Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

By Natalie Themm | Published February 8, 2024

Clene Inc. (NASDAQ: CLNN) Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

Posted in BioUtah News | Tagged | Comments Off on Clene Inc. Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

By Natalie Themm | Published February 8, 2024

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

Posted in BioUtah News | Tagged | Comments Off on Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

By Natalie Themm | Published February 8, 2024

This technology will support the development of Halia’s new Alzheimer’s disease drug, HT-4253, targeting a mediator of neuroinflammation called Leucine-rich repeat kinase 2 (LRRK2)

Posted in BioUtah News | Tagged | Comments Off on Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

AdvaMed Announces New Chair of State Medtech Alliance

By Natalie Themm | Published February 8, 2024

AdvaMed Announces New Chair of State Medtech Alliance

Posted in BioUtah News | Tagged | Comments Off on AdvaMed Announces New Chair of State Medtech Alliance

AI Utah Annouces Inaugural AI Utah 100 List

By Natalie Themm | Published February 1, 2024

AI Utah Annouces Inaugural AI Utah 100 List

Posted in BioUtah News | Tagged | Comments Off on AI Utah Annouces Inaugural AI Utah 100 List

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

By Natalie Themm | Published February 1, 2024

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

A Special Thanks To Our Legacy and Platinum Elite Members